PetVivo Holdings, Inc. PETV
Set alert
0.68 USD 0.00 +0.15%
At close · Oct 30
0.64 Day range 0.645
0.59 52-week range 1.45
- YTD
- -40.26%
- 1 year
- -52.04%
- Open
- 0.64
- Prev close
- 0.68
- Mkt cap
- 25.84M
- Vol
- 102
- Avg vol
- 11.26K
- EPS
- -0.34
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.64
- High
- 0.645
- Forward P/E
- -0.96
- Beta
- 2.10
- Short ratio
- 4.45
- Inst. own
- 5.27%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.92812
- 200-d avg
- 1.35
- 1y target
- 0.00
3M chart
Signals (13)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 21, 2026 | 1 week ago |
| SMA: Bullish | Oct 13, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 12, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 12, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 2, 2026 | 1 month ago |
| RSI: Overbought | Sep 21, 2026 | 1 month ago |
| SMA: Bullish | Sep 16, 2026 | 1 month ago |
| SMA: Bullish | Sep 9, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| SMA: Bearish | Sep 2, 2026 | 2 months ago |
| SMA: Bullish | Sep 1, 2026 | 2 months ago |
| SMA: Bearish | Aug 25, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 10, 2026 | 2 months ago |
Key statistics
- Market cap
- 12.07M
- Enterprise value
- 14.82M
- Trailing P/E
- 0.00
- Forward P/E
- -0.96
- PEG ratio
- 0.00
- Price / sales
- 11.54
- Price / book
- 12.00
- EPS (TTM)
- -0.85
- Beta
- 2.10
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 1.05M
- Revenue growth
- 16.80%
- Free cash flow
- -4.02M
- Total cash
- 80.08K
- Total debt
- 1.40M
- Return on equity
- -1266.46%
- Shares outstanding
- 16.77M
- Short % of float
- 1.00%
- 50-day average
- 0.92812
- 200-day average
- 1.35
Analyst view
Consensus: buy
Buy
Price target (mean) 0.00
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
PETV Revenue — quarterly 595.89K
PETV Net income — quarterly -1.75M
PETV EPS — quarterly -0.12
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 14, 2024 | Sep 1, 2024 | 0.00 | -0.11 | — | — |
| Aug 14, 2024 | Jun 1, 2024 | 0.00 | -0.11 | — | — |
| Jun 28, 2024 | Mar 1, 2024 | 0.00 | -0.14 | — | — |
| Feb 12, 2024 | Dec 1, 2023 | 0.00 | -0.12 | — | — |
| Nov 14, 2023 | Sep 1, 2023 | 0.00 | -0.23 | — | — |
| Aug 10, 2023 | Jun 1, 2023 | 0.00 | -0.25 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 11, 2021 | ThinkEquity | init | — | Buy |
About PetVivo Holdings, Inc.
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- petvivo.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on PETV — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CASH GREGORY D | Director | Conversion of Exercise of derivative security | Jun 29, 2022 | 59,267 |
| COSTANTINO ROBERT J | Director | Purchase | Mar 14, 2023 | 9,703 |
| DEMING DAVID DON | Director | Stock Award(Grant) | Sep 30, 2021 | 29,890 |
| DOLAN JOHN FITZGERALD | Officer and Director | Stock Award(Grant) | Sep 8, 2021 | 541,239 |
| JASPER JOSEPH WILLIAM | Director | Purchase | Mar 12, 2023 | 0 |
| JOHNSON SCOTT MITCHELL | Director | Stock Award(Grant) | Sep 30, 2021 | 169,726 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Bard Associates Inc. | 6.15% | 436,500 | 859.90K | Jun 29, 2023 |
| Vanguard Group Inc | 3.29% | 233,055 | 459.12K | Jun 29, 2023 |
| Geode Capital Management, LLC | 0.66% | 47,045 | 92.68K | Jun 29, 2023 |
| State Street Corporation | 0.65% | 46,229 | 91.07K | Jun 29, 2023 |
| Regal Investment Advisors, LLC | 0.30% | 21,377 | 42.11K | Jun 29, 2023 |
| Asset Dedication, Llc | 0.21% | 14,569 | 28.70K | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.44% | 173,200 | 341.20K | Jun 29, 2023 |
| Vanguard Extended Market Index Fund | 0.84% | 59,855 | 117.91K | Jun 29, 2023 |
| Fidelity Extended Market Index Fund | 0.39% | 27,820 | 57.87K | May 30, 2023 |
| Fidelity NASDAQ Composite Index Fund | 0.17% | 12,298 | 25.58K | May 30, 2023 |
| Fidelity Series Total Market Index Fund | 0.05% | 3,291 | 6.84K | May 30, 2023 |